Locations:
Search
Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC
Immunological pressure driving genetic mutations
New review published in Cancers suggests a synergistic benefit
Clinicians highlight the need to educate patients about warning signs
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
A new analysis emphasizes the value of a multi-disciplinary approach.
Multicenter effort aims to standardize information about diagnosis and early management
Use of MRI adds to cost but remains cost-effective due to higher sensitivity
This approach led to local control for patients with brain metastases more than 2 cm in diameter
Strategies and risk models are evolving for this asymptomatic condition
Advertisement
Advertisement